Diseases: Page 2

Alveo Technologies to develop avian influenza A(H5) test with CDC
By LabPulse.com staff writers
Under the agreement with the CDC, Alveo Technologies will develop a rapid diagnostic to detect and differentiate between influenza A and B and influenza A/H5, also known as the avian influenza subtype, in humans.
November 14, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Mainz Biomed, Thermo Fisher collaborate on CRC screening test
By LabPulse.com staff writers
Mainz Biomed and Thermo Fisher Scientific will jointly develop and potentially commercialize Mainz Biomed's next-generation colorectal cancer (CRC) screening test.
November 12, 2024
Colorectal Cancer Social
Veravas, Phanes Biotech to collaborate on Alzheimer's tau pathology assay
By LabPulse.com staff writers
Clinical diagnostics developer Veravas and Phanes Biotech have announced that they will co-develop a blood-based Alzheimer’s disease (AD) tau pathology test.
November 8, 2024
Alzheimers Tau Tangles Social
Sunbird Bio shares new data on blood-based Parkinson's diagnostic
By LabPulse.com staff writers
Biotech firm Sunbird Bio announced new data from a study demonstrating that Sunbird's technology could provide blood-based diagnosis of Parkinson's disease and other neurodegenerative diseases with a high level of accuracy.
November 1, 2024
Parkinsons Lewy Bodies Social
Oxford Nanopore, U.K. government partner on pandemic early warning system
By LabPulse.com staff writers
Oxford Nanopore and the U.K. government will create the world's first real-time biosurveillance system to monitor infectious disease outbreaks and assess the threat of emerging pandemics.
November 6, 2024
Lab Virus Bacteria Research Social
Inify, Karolinska Institutet partner on AI-driven prostate cancer diagnostics
By LabPulse.com staff writers
Digital pathology firm Inify Laboratories is collaborating with scientists at the Karolinska Institutet in Stockholm on a project aimed at improving the precision of prostate cancer diagnosis through artificial intelligence (AI)-driven image analysis.
November 5, 2024
Cancer Cells Prostate Social
CMS Medicare fee schedule includes blood tests for CRC screening
By LabPulse.com staff writers
In the 2025 Medicare Physician Fee Schedule final rule, the U.S. Centers for Medicare and Medicaid Services (CMS) updated coverage for a complete colorectal cancer (CRC) screening to include Medicare-covered blood-based biomarker CRC screening tests.
November 5, 2024
Blood Test Samples Lab Social
Alzheimer's panel validated in University of Pittsburgh study
By LabPulse.com staff writers
A team at the University of Pittsburgh has validated a new blood test panel that can simultaneously measure over 100 Alzheimer's disease biomarkers.
November 4, 2024
Alzheimers Tau Tangles Social
Abzena expands QC and analytical microbiology laboratories
By LabPulse.com staff writers
Early drug development phase bioassay developer Abzena has expanded its microbiology laboratory facility in San Diego.
October 31, 2024
Laboratory Software Social
WHO lists 2 more mpox tests under its emergency use procedure
By LabPulse.com staff writers
The World Health Organization (WHO) has listed two additional IVD tests under its emergency use listing procedure.
October 30, 2024
Monkeypox Virus Social
Caris Life Sciences embarks on 10K-sample breast cancer biomarker analysis project
By LabPulse.com staff writers
Caris will perform comprehensive molecular characterization of TAILORx tissue samples.
October 25, 2024
Dna Sequence (1)
New York State OKs NeoGenomics' pancancer solid tumor, targeted lung NGS tests
By LabPulse.com staff writers
The New York State Department of Health has granted conditional approval for two NeoGenomics' next-generation sequencing (NGS) tests.
October 22, 2024
Lab Blood Dna
Previous Page
Page 2 of 293
Next Page